Literature DB >> 1291875

Immunogenic potential of Aspergillus nidulans subcellular fractions and their polypeptide components.

P Puente1, N Fernández, M C Ovejero, F Leal.   

Abstract

Cell-free extracts of the ascomycetous fungus Aspergillus nidulans were separated into three subcellular fractions: cell walls, total membranes and cytosol, and two different immunization protocols were used to raise antibodies against them in 12 New Zealand rabbits. The immune response was followed over time by dot and Western blot analyses to determine the immunogenic potential of each individual fraction and their polypeptide components. The IgG fractions, purified from pools of the best sera, were used to analyze in detail the antigenic composition of A. nidulans mycelium. The fast immunization protocol provided a much earlier response and higher sera titres. Cytosols and membranes were more immunogenic than cell walls and, in most cases, a positive correlation was shown between the titre of each serum and the number of detected antigens. The polypeptides of A. nidulans included six major immunodominant antigens of the molecular weights ranging between 13 and 200 kDa.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1291875     DOI: 10.1111/j.1439-0507.1992.tb00854.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  3 in total

1.  Zinc-regulated biosynthesis of immunodominant antigens from Aspergillus spp.

Authors:  M Segurado; R López-Aragón; J A Calera; J M Fernández-Abalos; F Leal
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Uptake of Aspergillus fumigatus Conidia by phagocytic and nonphagocytic cells in vitro: quantitation using strains expressing green fluorescent protein.

Authors:  Julie A Wasylnka; Margo M Moore
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

3.  Variability of Aspergillus nidulans antigens with media and time and temperature of growth.

Authors:  J A Calera; R López-Medrano; M C Ovejero; P Puente; F Leal
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.